The impact of KRAS mutations on the clinical outcome and immune response following immunotherapy for pancreatic cancer

Eric S. Christenson, Raymond Yu, Jessica Gai, Hao Wang, Ming Lei, Lei Zheng

Open source

DOI
10.21037/apc-24-2
Published
2024-06
Container
Annals of Pancreatic Cancer
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/apc-24-2,
  title = {The impact of KRAS mutations on the clinical outcome and immune response following immunotherapy for pancreatic cancer},
  author = {Eric S. Christenson and Raymond Yu and Jessica Gai and Hao Wang and Ming Lei and Lei Zheng},
  year = {2024},
  journal = {Annals of Pancreatic Cancer},
  doi = {10.21037/apc-24-2},
  url = {https://doi.org/10.21037/apc-24-2}
}

RIS

TY  - JOUR
TI  - The impact of KRAS mutations on the clinical outcome and immune response following immunotherapy for pancreatic cancer
AU  - Eric S. Christenson
AU  - Raymond Yu
AU  - Jessica Gai
AU  - Hao Wang
AU  - Ming Lei
AU  - Lei Zheng
PY  - 2024
JO  - Annals of Pancreatic Cancer
DO  - 10.21037/apc-24-2
UR  - https://doi.org/10.21037/apc-24-2
ER  - 

APA

Christenson, E. S., Yu, R., Gai, J., Wang, H., Lei, M., & Zheng, L. (2024). The impact of KRAS mutations on the clinical outcome and immune response following immunotherapy for pancreatic cancer. Annals of Pancreatic Cancer. https://doi.org/10.21037/apc-24-2

Source records